WASHINGTON (Reuters) - It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.